Allergan Has A Bone To Pick With Bill Ackman, Valeant

An insider trading-shaped bone.

Allergan Inc, which is fighting a $51 billion hostile takeover bid from Valeant Pharmaceuticals International and activist investor William Ackman, on Friday filed a federal lawsuit alleging they violated insider trading laws and engaged in other fraudulent practices. The suit alleges that Ackman’s hedge fund, Pershing Square Capital Management between February and April bought Allergan stock and securities then valued at over $3.2 billion “while fully aware of Valeant`s nonpublic takeover intentions.”

Allergan sues Valeant, Ackman for alleged insider trading [Reuters]

(hidden for your protection)
Show all comments

4 Responses to “Allergan Has A Bone To Pick With Bill Ackman, Valeant”

  1. guest says:

    I've got an insider trading shaped boner.
    -guy who's a 7th grader at heart

  2. Parabolic says:

    only one post all day — weak